Borderline ovarian tumors: Consensus, controversy, and continuing challenges

Pathology Case Reviews

Volumn 11, Issue 1, 2006, Pages 9-17

  Silverberg, Steven G ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Borderline tumors; Controversies; Ovary

Indexed keywords

BORDERLINE OVARIAN TUMOR; CANCER CLASSIFICATION; CANCER GRAFT; CANCER INVASION; CARCINOMA IN SITU; CELL ULTRASTRUCTURE; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; FEMALE; HISTOLOGY; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MUCINOUS CARCINOMA; OVARY TUMOR; PERITONEUM PSEUDOMYXOMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; TUMOR BIOPSY; UTERINE CERVIX CARCINOMA;

EID: 33746657259     PISSN: 10829784     EISSN: 15334015     Source Type: Journal    
DOI: 10.1097/01.pcr.0000196556.41743.cd     Document Type: Review

References (51)

1. Taylor HC Jr. Malignant and semimalignant tumors of the ovary. Surg Gynecol Obstet. 1929;48:204-230.
2. Berman JJ. Borderline ovarian tumor workshop, Bethesda, Maryland, August 27-28, 2003. Hum Pathol. 2004;35:907-909.
3. Silverberg SG, Bell DA, Kurman RJ, et al. Borderline ovarian tumors: key points and workshop summary. Hum Pathol. 2004;35:910-917.
4. Seidman JD, Soslow RA, Vang R, et al. Borderline ovarian tumors: diverse contemporary viewpoints on terminology and diagnostic criteria with illustrative images. Hum Pathol. 2004;35:918-933.
5. Bell DA, Longacre TA, Prat J, et al. Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: workshop perspectives. Hum Pathol. 2004;35:934-948.
6. Ronnett BM, Kajdacsy-Balla A, Gilks CB, et al. Mucinous borderline ovarian tumors: points of general agreement and persistent controversies regarding nomenclature, diagnostic criteria, and behavior. Hum Pathol. 2004;35:949-960.
7. Sherman ME, Berman JJ, Birrer MJ, et al. Current challenges and opportunities for research on borderline ovarian tumors. Hum Pathol. 2004;35:961-970.
8. Serov SF, Scully RE, Sobin LH. Histologic typing of ovarian tumors. In: World Health Organization, International Histological Classification and Staging of Tumors. Geneva, Switzerland: World Health Organization; 1973.
9. Lee KR, Tavassoli FA, Prat J, et al. Tumors of the ovary and peritoneum: surface epithelial-stromal tumours. In: Tavassoli FA, Devilee P, eds. Pathology and Genetics of Tumours of the Breast and Female Genital Organs, World Health Organization Classification of Tumors. Lyon: IARC Press; 2003:113-145.
10. Scully RE, Young RH, Clement PB. Tumors of the Ovary, Maldeveloped Gonads, Fallopian Tube, and Broad Ligament: Atlas of Tumor Pathology, Third Series, Fascicle 23. Washington, DC: Armed Forces Institute of Pathology; 1998:51-168.
11. Russell P. Ovarian epithelial tumors with atypical proliferation. In: Low D, Fox H, eds. Advances in Gynaecological Pathology. New York, NY: Churchill Livingstone; 1992:299-320.
12. Seidman JD, Kurman RJ. Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. Hum Pathol. 2000;31:539-557.
13. Bell DA. Origins and molecular pathology of ovarian cancer. Mod Pathol. 2005;18:S19-S32.
14. Hart WR. Borderline epithelial tumors of the ovary. Mod Pathol. 2005;18:S33-S50.
15. Purdie DM, Webb PM, Siskind V, et al. The different etiologies of mucinous and nonmucinous ovarian cancers. Gynecol Oncol. 2002;88:S145-S148.
16. Riman T, Dickman PW, Nilsson S, et al. Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study. Gynecol Oncol. 2001;83:575-585.
17. Hoerl MD, Hart WR. Primary ovarian mucinous cystadenocarcinomas: a clinicopathologic study of 49 cases with long-term follow-up. Am J Surg Pathol. 1998;22:1449-1462.
18. Nayar R, Siriaunkgul S, Robbins KM, et al. Microinvasion in low malignant potential tumors of the ovary. Hum Pathol. 1996;27:521-527.
19. Gilks CB. Subclassification of ovarian surface epithelial tumors based on correlation of histologic and molecular pathologic data. Int J Gynecol Pathol. 2004;23:200-205.
20. Hart WR. Mucinous tumors of the ovary: a review. Int J Gynecol Pathol. 2004;24:4-25.
21. Burks RT, Sherman ME, Kurman RJ. Micropapillary serous carcinoma of the ovary: a distinctive low-grade carcinoma related to serous borderline tumors. Am J Surg Pathol. 1996;20:1319-1330.
22. Smith-Sehdev AE, Sehdev PS, Kurman RJ. Noninvasive and invasive micropapillary (low-grade) serous carcinoma of the ovary: a clinicopathologic analysis of 135 cases. Am J Surg Pathol. 2003;27:725-736.
23. Segal GH, Hart WR. Ovarian serous tumors of low malignant potential (serous borderline tumors): the relationship of exophytic surface tumor to peritoneal "implants". Am J Surg Pathol. 1992;16:577-583.
24. Staebler A, Heselmeyer-Haddadd K, Bell K, et al. Micropapillary serous carcinoma of the ovary has distinct patterns of chromosomal imbalances by comparative genomic hybridization compared with atypical proliferative serous tumors and serous carcinomas. Hum Pathol. 2002;33:47-59.
25. Singer G, Shih I-M, Truskinovsky A, et al. Mutational analysis of K-ras segregates ovarian serous carcinoma into two types: invasive MPSC (low-grade tumor) and conventional serous carcinoma (high grade tumor). Int J Gynecol Pathol. 2002;22:37-41.
26. Gu J, Roth LM, Younger C, et al. Molecular evidence for the independent origin of extra-ovarian papillary serous tumors of low malignant potential. J Natl Cancer Inst. 2001;93:1147-1152.
27. Lu KH, Bell DA, Welch WR, et al. Evidence for the multifocal origin of bilateral and advanced human serous borderline ovarian tumors. Cancer Res. 1998;58:2328-2330.
28. Ortiz BH, Ailawadi M, Colitti C, et al. Second primary or recurrence? comparative patterns of p53 and K-ras mutations suggest that serous borderline ovarian tumors and subsequent serous carcinomas are unrelated tumors. Cancer Res. 2001;61:7264-7267.
29. Sieben NLG, Kolkman-Uljee SM, Flanagan AM, et al. Molecular genetic evidence for monoclonal origin of bilateral ovarian serous borderline tumors. Am J Pathol. 2003;162:1095-1101.
30. Bostwick DG, Tazelaar HD, Ballon SC, et al. Ovarian epithelial tumors of borderline malignancy: a clinical and pathologic study of 109 cases. Cancer. 1986;58:2052-2065.
31. Michael H, Roth LM. Invasive and noninvasive implants in ovarian serous tumors of low malignant potential. Cancer. 1986;57:1240-1247.
32. Gershenson DM, Silva EG. Serous ovarian tumors of low malignant potential with peritoneal implants. Cancer. 1990;65:578-585.
33. Bell DA, Weinstock MA, Scully RE. Peritoneal implants of ovarian serous borderline tumors: histologic features and prognosis. Cancer. 1988;62:2212-2222.
34. Bell KA, Smith-Sehdev AE, Kurman RJ. Refined diagnostic criteria for implants associated with ovarian atypical proliferative serous tumors (borderline) and micropapillary serous carcinomas. Am J Surg Pathol. 2001;25:419-432.
35. Silva EG, Tornos C, Zhuang Z, et al. Tumor recurrence in stage I ovarian serous neoplasms of low malignant potential. Int J Gynecol Pathol. 1998;17:1-6.
36. Moore WF, Bentley RC, Berchuck A, Robboy SJ. Some müllerian inclusion cysts in lymph nodes may sometimes be metastases from serous borderline tumors of the ovary. Am J Surg Pathol. 2000;24:710-718.
37. Alvarez AA, Moore WF, Robboy SJ, et al. K-ras mutations in müllerian inclusion cysts associated with serous borderline tumors of the ovary. Gynecol Oncol. 2001;80:201-206.
38. Hart WR, Norris HJ. Borderline and malignant mucinous tumors of the ovary: histologic criteria and clinical behavior. Cancer. 1973;31:1031-1045.
39. Siriaunkgul S, Robbins KM, McGowan L, et al. Ovarian mucinous tumors of low malignant potential: a clinicopathologic study of 54 tumors of intestinal and müllerian type. Int J Gynecol Pathol. 1995;14:198-208.
40. Lee KR, Young RH. The distinction between primary and metastatic mucinous carcinomas of the ovary: gross and histologic findings in 50 cases. Am J Surg Pathol. 2003;27:281-292.
41. Riopel MA, Ronnett BM, Kurman RJ. Evaluation of diagnostic criteria and behavior of ovarian intestinal-type mucinous tumors: atypical proliferative (borderline) tumors and intraepithelial, microinvasive, invasive, and metastatic carcinomas. Am J Surg Pathol. 1999;23:617-635.
42. Seidman JD, Kurman RJ, Ronnett BM. Primary and metastatic mucinous adenocarcinomas in the ovaries: incidence in routine practice with a new approach to improve intraoperative diagnosis. Am J Surg Pathol. 2003;27:985-993.
43. Cathro HP, Stoler MH. Expression of cytokeratins 7 and 20 in ovarian neoplasia. Am J Clin Pathol. 2002;117:944-951.
44. Ji H, Isacson C, Seidman JD, et al. Cytokeratins 7 and 20, Dpc4, and MUC5AC in the distinction of metastatic mucinous carcinomas in the ovary from primary ovarian mucinous tumors: Dpc4 assists in identifying metastatic pancreatic carcinomas. Int J Gynecol Pathol. 2002;21:391-400.
45. Ronnett BM, Kurman RJ, Shmookler BM, et al. The morphologic spectrum of ovarian metastases of appendiceal adenocarcinomas: a clinicopathologic and immunohistochemical analysis of tumors often misinterpreted as primary ovarian tumors or metastatic tumors from other gastrointestinal sites. Am J Surg Pathol. 1997;21:1144-1155.
46. Ronnett BM, Zahn CM, Kurman RJ, et al. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis: a clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei". Am J Surg Pathol. 1995;19:1390-1408.
47. Rutgers J, Scully RE. Ovarian müllerian mucinous papillary cystadenomas of borderline malignancy: a clinicopathologic analysis. Cancer. 1998;61:340-348.
48. Dube V, Roy M, Plante M, et al. Mucinous ovarian tumors of müllerian-type: an analysis of 17 cases including borderline tumors and intraepithelial, microinvasive, and invasive carcinomas. Int J Gynecol Pathol. 2005;24:138-146.
49. Rodriguez IM, Irving JA, Prat J. Endocervical-like mucinous borderline tumors of the ovary: a clinicopathologic analysis of 31 cases. Am J Surg Pathol. 2004;28:1311-1318.
50. Shappell HW, Riopel MA, Smith-Sehdev AE, et al. Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas. Am J Surg Pathol. 2002;26:1529-1541.
51. Lee KR, Nucci MR. Ovarian mucinous and mixed epithelial carcinomas of müllerian (endocervical-like) type: a clinicopathologic analysis of four cases of an uncommon variant associated with endometriosis. Int J Gynecol Pathol. 2003;22:42-51.